Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIASA 3: Glucose metabolism in South Asian women with pre-diabetes
2018-000823-15Phase 4Terminated
- Sponsor
- Oslo University Hospital
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin, pioglitazone, empagliflozin and linagliptin in prediabetes, impaired fasting glucose (IFG) and type 2 diabetes mellitus (T2DM), sponsored by Oslo University Hospital. Started Mar 2019; status: terminated.
02
Drugs
metforminpioglitazoneempagliflozinlinagliptin
03
Conditions
prediabetesimpaired fasting glucose (IFG)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2018-000823-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000823-15.